84792-41-6 Usage
General Description
"(R)-[(allyloxy)carbonylamino](4-hydroxyphenyl)acetic acid" is a chemical compound with a molecular formula of C13H15NO5. It is a chiral molecule, with the (R)-enantiomer being the active form. (R)-[(allyloxy)carbonylamino](4-hydroxyphenyl)acetic acid has both an amine and a carboxylic acid functional group, as well as a hydroxyphenyl group. It is used in the synthesis of pharmaceutical drugs and other organic compounds. (R)-[(allyloxy)carbonylamino](4-hydroxyphenyl)acetic acid has potential applications in the field of medicine and biochemistry due to its unique chemical structure and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 84792-41-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,7,9 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 84792-41:
(7*8)+(6*4)+(5*7)+(4*9)+(3*2)+(2*4)+(1*1)=166
166 % 10 = 6
So 84792-41-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H13NO5/c1-2-7-18-12(17)13-10(11(15)16)8-3-5-9(14)6-4-8/h2-6,10,14H,1,7H2,(H,13,17)(H,15,16)
84792-41-6Relevant articles and documents
An improved solid-phase methodology for the synthesis of putative hexa- and heptapeptide intermediates in vancomycin biosynthesis
Li, Dong Bo,Robinson, John A.
, p. 1233 - 1239 (2007/10/03)
The biosynthesis of the vancomycin aglycone involves three oxidative phenol coupling reactions, each catalyzed by a discrete cytochrome P450-like enzyme. Studies on the mechanism and specificity of the enzyme (called OxyB) catalyzing the first coupling, require access to suitable linear peptide precursors, each conjugated as a thioester to a peptide carrier domain of the vancomycin non-ribosomal peptide synthetase. An efficient route to representative free linear peptides is described here. The method makes use of Alloc-chemistry during solid-phase assembly of the peptide backbone, but importantly and in contrast to earlier efforts, largely avoids the use of amino acid side chain protecting groups. In this way, the target linear peptides can be released directly from the solid support under very mild conditions. The Royal Society of Chemistry 2005.
